Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycoprotein precursor of the Crimean-Congo hemorrhagic fever virus (CCHFV) is encoded by the M segment of the viral genome. This large precursor protein undergoes complex posttranslational processing, generating mature glycoproteins Gn and Gc, which are essential for viral entry. Cleavage by furin produces GP38, a secreted glycoprotein involved in immune modulation. The glycoproteins are key targets for diagnostics and vaccine development.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Precursor (CCHFV Glycoprotein Precursor).